DEF 14A: KindlyMD Seeks Stockholder Approval for Director Re-election and Accounting Firm Ratification at 2024 Annual Meeting

KindlyMD is holding its annual stockholder meeting on November 8, 2024, to re-elect its five directors and ratify the selection of Sadler Gibb & Associates as its independent accounting firm.

Summary

• KindlyMD will hold its 2024 Annual Meeting of Stockholders on November 8, 2024, at its Salt Lake City corporate offices.
• The primary purposes of the meeting are to re-elect five directors to one-year terms and to ratify the selection of Sadler Gibb & Associates as the company's independent public accounting firm for the year ending December 31, 2024.
• The Board of Directors recommends voting FOR the re-election of the nominated directors and FOR the ratification of Sadler Gibb & Associates.
• Stockholders of record as of August 6, 2024, are entitled to vote at the meeting.
• Proxy materials were first furnished to stockholders on approximately September 27, 2024.
• Executive officers and directors controlling approximately 50.2% of the outstanding stock have indicated their intent to vote in favor of the proposals.
• The company is soliciting proxies and will bear the costs of solicitation.
• The company has adopted a Code of Ethics for its Board of Directors and a Code of Conduct for all employees.
• The company is committed to a diverse, inclusive, and equitable environment for all board members.
• The Board of Directors has determined that all three outside directors constituting 60% of its Board of Directors are independent.

Sentiment

Score: 7

Explanation: The document is primarily informational and procedural, with a neutral to slightly positive tone. The management expresses gratitude for stockholder ownership, contributing to the slightly positive sentiment.

Positives

• The Board of Directors is recommending a vote FOR the re-election of the current directors.
• The Board of Directors is recommending a vote FOR the ratification of the appointment of Sadler Gibb & Associates as the independent accounting firm.
• The company has established Audit, Governance and Nominating, and Compensation Committees.
• The company has adopted a Code of Ethics for its Board of Directors and a Code of Conduct for all employees.
• The Board of Directors has determined that all three outside directors constituting 60% of its Board of Directors are independent.

Negatives

• The company forgave a $300,000 note payable to Wade Rivers, LLC, resulting in an increase to additional paid-in capital, which may indicate financial challenges.
• The aggregate total of accounting fees (audit and tax) was $108,099 in 2023 compared to $66,880 in 2022, which may indicate increased complexity or scrutiny of the company's financials.

Risks

• Failure to re-elect the nominated directors could lead to instability in the company's leadership.
• Failure to ratify the selection of Sadler Gibb & Associates as the independent accounting firm could require the Audit Committee to reconsider its selection, potentially leading to increased costs and disruption.
• The company's reliance on related party transactions, such as the note payable to Wade Rivers, LLC, could raise concerns about conflicts of interest.
• The company's compliance with securities laws and regulations is subject to ongoing scrutiny and could be impacted by changes in the regulatory environment.
• The company's ability to attract and retain qualified personnel, including executive officers and directors, is critical to its success.

Future Outlook

The company anticipates holding its next Annual Meeting of Stockholders during September 2025.

Management Comments

• KindlyMD has always maintained an open invitation for stockholders to call management directly with questions and/or concerns, AT ANY TIME.
• Thank you for your ownership in KindlyMD!

Industry Context

The document reflects standard corporate governance practices for publicly held companies, including the solicitation of proxies, election of directors, and ratification of independent auditors. The focus on non-opioid medicine access aligns with broader healthcare trends aimed at addressing the opioid crisis.

Comparison to Industry Standards

• The proxy statement follows standard SEC guidelines for disclosure and shareholder voting.
• The director independence criteria align with Nasdaq Stock Market Rules.
• The CEO pay ratio disclosure is now a common practice among publicly traded companies, as mandated by the Dodd-Frank Act.
• The company's approach to board diversity is consistent with increasing emphasis on diversity and inclusion in corporate governance.

Related Party Transactions

• On April 15, 2023, the Company entered into a long-term unsecured note payable with Wade Rivers, LLC, an entity that is beneficially owned by The Wade Rivers Trust, for which Mr. Pickett and his spouse serve as trustees, for $332,545.
• On December 31, 2023, the note was fully forgiven by Wade Rivers, LLC, resulting in an increase of $300,000 to additional paid-in capital.

Stakeholder Impact

• Shareholders are asked to vote on key governance matters, influencing the direction and oversight of the company.
• Employees are indirectly affected by decisions regarding executive compensation and company performance.
• The company's choice of accounting firm impacts the credibility and reliability of its financial reporting.

Next Steps

• Stockholders are encouraged to vote on the proposals outlined in the proxy statement.
• The company will hold its Annual Meeting of Stockholders on November 8, 2024.
• The company will file a current report on Form 8-K with the SEC within four business days of the meeting to announce the final voting results.
• Stockholders may submit proposals for inclusion in the 2025 Proxy Statement by May 1, 2025.

Key Dates

Keywords

proxy statement, annual meeting, directors, accounting firm, Sadler Gibb & Associates, executive compensation, audit committee, corporate governance, stockholders, KindlyMD